A Phase 1 TP-271 Oral PK Single Ascending Dose Study
NCT03024034
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class
Conditions
Bacterial Infections
Interventions
DRUG:
TP-271
Sponsor
Tetraphase Pharmaceuticals, Inc
Collaborators
[object Object]